Overseas Contractor Bill Could Give Pharma Federal Contracting Headaches In U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
House bill would bar firms in violation of the Foreign Corrupt Practices Act from federal contracts or grants.